http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006047326-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_115aca8c47345aeb19a04443f4f64e36
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36014
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-18
filingDate 2004-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e686ce79321f68fca99111d0bc184c47
publicationDate 2006-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2006047326-A1
titleOfInvention Application of specific neuromodulation waveforms to reduce symptoms of neurological disorders
abstract A preferred form of the invention can reactivate proprioception system neural pathways by means of specific neuromodulation waveforms, application points and procedures. The improvement and advancement of this invention is the ability to significantly improve the quality of life of people with movement disorders caused by loss of neural transmission in the proprioception system. Unlike present transcutaneous electrical stimulation (TENS) devices this invention addresses movement disorders as a closed loop control system malfunction and not as a pain management problem. This invention has been shown to relieve leg neuropathy, reduce Parkinson's disease tremor and rigidity, and allow frozen shoulders to be completely restored.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11730958-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9387338-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10960207-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011178571-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10905879-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014148870-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10179238-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11344722-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10765856-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10307591-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10786669-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11229789-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11628300-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10549093-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10946185-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11291828-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11247053-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10918853-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11596785-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11077301-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10016600-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10814130-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11458311-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9452287-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9002477-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11331480-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008129555-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11541237-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008129555-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10850090-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9757584-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10625074-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11224742-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9802041-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10561839-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10953225-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10173060-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7837719-B2
priorityDate 2004-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID681
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399686

Total number of triples: 51.